Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
Disposable bioreactors: a cost-saving innovation

Companies who manufacture biotechnology products such as monoclonal antibodies, therapeutic proteins and vaccines, produce a wide range of product…


Reindustrialization of Europe with a €3.7 billion investment in green industries

The bioeconomy uses renewable resources instead of fossil resources. Biorefineries play a central role in intelligently converting biomass and was…


9.36 million euros for the Bio Base Europe Pilot Plant

ERDF Flanders and Bio Base Europe Pilot Plant (BBEPP) signed an agreement for an investment of €9,36 million within the framework of the IMPACT pr…

POPULAR TAGS

Q-Biologicals becomes part of Amatsigroup

Written by LVS on in the category news with the tags , .


French pharmaceutical conglomerate Amatsigroup has announced its acquisition of Q-Biologicals. Q-Biologicals was founded in 2011 as a VIB/UGent spin-off by several Innogenetics veterans and provides services in process development and biomanufacturing. Their GMP manufacturing processes of recombinant proteins, monoclonal antibodies and vaccines have successfully aided in more than 75 R&D projects.

With this consolidation, Amatsigroup continues its expansive strategy. Back in 2014 the French contract development manufacturing organization for human and veterinary pharmaceuticals also incorporated the Ghent-based SEPS Pharma into the Amatsigroup family. Now named AmatsiSEPS, the company focusses on enhanced bioavailability and oral formulation of drugs.

Former Q-Biologicals shareholders were VIB and the Flemish investment funds PMV and Fund+. The total sum of the acquisition was undisclosed.

Read more about: , .

RELATED ARTICLES
Disposable bioreactors: a cost-saving innovation

Companies who manufacture biotechnology products such as monoclonal antibodies, therapeutic proteins and vaccines, produce a wide range of product…


Reindustrialization of Europe with a €3.7 billion investment in green industries

The bioeconomy uses renewable resources instead of fossil resources. Biorefineries play a central role in intelligently converting biomass and was…


9.36 million euros for the Bio Base Europe Pilot Plant

ERDF Flanders and Bio Base Europe Pilot Plant (BBEPP) signed an agreement for an investment of €9,36 million within the framework of the IMPACT pr…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

Flanders.bio XpandInnovation UGent Turnstone Biowin Itera Life Science Janssen V-Bio Ventures GSK KU Leuven

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.